These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 30682563)

  • 21. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China.
    Ding Y; Zhang J; Yao K; Gao W; Wang Y
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):833-840. PubMed ID: 33118058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
    Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
    Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans in Mexico, including subclone ST131-B2-O25:H4-H30-Rx.
    Cortés-Cortés G; Lozano-Zarain P; Torres C; Alonso CA; Ríos-Torres AM; Castañeda M; López-Pliego L; Navarro A; Del Carmen Rocha-Gracia R
    J Glob Antimicrob Resist; 2017 Jun; 9():130-134. PubMed ID: 28552831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mcr-1 encoding colistin resistance in CTX-M-1/CTX-M-15- producing Escherichia coli isolates of bovine and caprine origins in Tunisia. First report of CTX-M-15-ST394/D E. coli from goats.
    Hassen B; Saloua B; Abbassi MS; Ruiz-Ripa L; Mama OM; Hassen A; Hammami S; Torres C
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101366. PubMed ID: 31627036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
    Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
    BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of O25b-ST131 clone, CTX-M-1 and CTX-M-15 genes via real-time PCR in Escherichia coli strains in patients with UTIs obtained from a university hospital in Istanbul.
    Demirci M; Ünlü Ö; İstanbullu Tosun A
    J Infect Public Health; 2019; 12(5):640-644. PubMed ID: 30826300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Escherichia coli Producing CTX-M-1-Group Extended-Spectrum β-Lactamases from Pigs in Aichi Prefecture, Japan, between 2015 and 2016.
    Norizuki C; Kawamura K; Wachino JI; Suzuki M; Nagano N; Kondo T; Arakawa Y
    Jpn J Infect Dis; 2018 Jan; 71(1):33-38. PubMed ID: 29279444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissemination and characterisation of Escherichia coli producing extended-spectrum β-lactamases, AmpC β-lactamases and metallo-β-lactamases from livestock and poultry in Northeast India: A molecular surveillance approach.
    Tewari R; Mitra S; Ganaie F; Das S; Chakraborty A; Venugopal N; Shome R; Rahman H; Shome BR
    J Glob Antimicrob Resist; 2019 Jun; 17():209-215. PubMed ID: 30634056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic landscape of ESBL producing international clone ST410 of
    Patil S; Pai L; Chen H; Chen Y; Xinye L; Dong S; Kaushik S; Lopes BS; Chen X; Liu S; Wen F
    Front Cell Infect Microbiol; 2024; 14():1403234. PubMed ID: 39324056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria.
    Alouache S; Estepa V; Messai Y; Ruiz E; Torres C; Bakour R
    Microb Drug Resist; 2014 Feb; 20(1):30-8. PubMed ID: 23952363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
    Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
    Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in humans and from food-producing animals in Italy: a 'One Health' study.
    Giufrè M; Mazzolini E; Cerquetti M; Brusaferro S;
    Int J Antimicrob Agents; 2021 Nov; 58(5):106433. PubMed ID: 34525400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.
    Yasir M; Ajlan AM; Shakil S; Jiman-Fatani AA; Almasaudi SB; Farman M; Baazeem ZM; Baabdullah R; Alawi M; Al-Abdullah N; Ismaeel NA; Shukri HA; Azhar EI
    Sci Rep; 2018 Oct; 8(1):14847. PubMed ID: 30287889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.